Responding to the updated draft guidance from NICE to not recommend Perjeta (pertuzumab) for routine NHS use after surgery for early HER2-positive...

17 August 2018

Responding to news that health officials are investigating concerns that adults who should have been invited for breast and bowel cancer screening...

11 August 2018

Perjeta, given in combination with Herceptin (trastuzumab) and docetaxel (a chemotherapy drug), is a first-line treatment for patients with HER2-...

10 August 2018

Discussing the news that NHS trusts are being encouraged to move away from the breast cancer drug Herceptin to use a biologically similar medicine,...

31 July 2018

We have responded to National Cancer Patient Experience Survey showing satisfaction with NHS cancer care is at a record high. ...

27 July 2018

The Secretary of State for Health and Social Care, Matt Hancock today outlined his commitments to workforce, technology and prevention, in his first...

20 July 2018

Responding to the publication of NICE’s updated guidance for early and locally advanced breast cancer, Samia al Qadhi, Chief Executive of Breast...

18 July 2018

Responding to the news that flight attendants are more likely to develop several forms of cancer than the average person, Addie Mitchell, Clinical...

26 June 2018

Responding to new evidence from the Institute of Cancer Research suggesting that higher BMIs in young women reduce their risk of breast cancer,...

21 June 2018